ArticleScientific reports2024
Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in endometriosis.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Obstetric and Neonatal Outcomes in Deep Infiltrating Versus Superficial Endometriosis: A Retrospective Cohort Study.Reproductive sciences (Thousand Oaks, Calif.) · 2026Article
- Article
- Article
- Research progress and potential therapeutic targets of a novel disulfide stress-driven cell death-disulfidptosis in gynecological tumors and other gynecological disorders.American journal of cancer research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Endometriosis (EMs) is the prevalent gynecological disease with the typical features of intricate pathogenesis and immune-related factors. Currently, there is no effective therapeutic intervention for EMs. Disulfidptosis, the cell death pattern discovered recently, may show close relationships to immunity and EMs. In this study, bioinformatics analysis was used to investigate the role of disulfide breakdown related genes (DRGs) in EMs. The EMs gene expression matrix was subjected to differential analysis for identifying overlap between differentially expressed genes (DEGs) in EMs and genes associated with disulfide poisoning. Immunoinfiltration analysis was performed. In addition, the association of hub genes with immune cells was examined. Multiple machine learning methods were employed to identify hub genes, construction of predictive models, and validation using external datasets and clinical samples. Totally 15 overlapping genes were identified. Immune-correlation analysis showed that NK cells played a vital role, and these 15 genes were closely related to NK cells. PDLIM1 was further determined as the hub gene through machine learning techniques. Clinical samples and external datasets were adopted for validating the performance in diagnosis. According to the above findings, we built the predictive model, and calculated the AUCs obtained from three external validation datasets to demonstrate the model accuracy. RT-qPCR and IHC analyses were applied to confirm the results. Colony formation was used to verify the effect of PDLIM1 on the proliferation of primary EMs cells. A strong correlation between disulfidptosis and EMs was identified in this study, highlighting its close correlation with the immune microenvironment. Moreover, our results shed new lights on exploring biomarkers and potential therapeutic targets for EMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.